Crescent Biopharma, Inc.
CBIO
$17.14
$0.513.07%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.41% | 743.39% | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 368.58% | 1,464.79% | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 16.07% | 756.31% | |||
|
|
|||||
| Total Current Assets | 16.07% | 756.31% | |||
| Net Property, Plant & Equipment | 19.28% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 14.15% | -54.25% | |||
| Total Assets | 16.09% | 677.70% | |||
|
|
|||||
| Total Accounts Payable | 54.25% | 87.70% | |||
| Total Accrued Expenses | -42.09% | -65.30% | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 123.22% | -- | |||
| Total Finance Division Other Current Liabilities | 287.26% | 828.72% | |||
| Total Other Current Liabilities | 287.26% | 828.72% | |||
| Total Current Liabilities | 10.70% | -0.64% | |||
|
|
|||||
| Total Current Liabilities | 10.70% | -0.64% | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -32.59% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 7.28% | -70.48% | |||
|
|
|||||
| Common Stock & APIC | 99.51% | 13,037.32% | |||
| Retained Earnings | -301.29% | -490.92% | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | 17.75% | 696.29% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 0.00% | 0.00% | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 0.00% | 0.00% | |||
|
|
|||||
| Total Common Equity | 17.75% | 696.29% | |||
| Total Preferred Equity | 0.00% | 0.00% | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 17.24% | 802.75% | |||
|
|
|||||